+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Auto-Injectors Market - Global Forecast 2026-2032- Product Image
Auto-Injectors Market - Global Forecast 2026-2032- Product Image
Sale

Auto-Injectors Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083867
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Auto-Injectors Market is projected to reach USD 11.22 Billion in 2026. It is expected to continue growing at a CAGR of 12.35%, reaching USD 22.63 Billion by 2032.

Auto-injectors are prefilled, patient-centered drug delivery devices designed to administer a measured dose with minimal steps, supporting rapid treatment in emergencies and routine self-administration for chronic diseases. The category spans spring-powered and electromechanical platforms used for epinephrine, biologics, biosimilars, migraine therapies, multiple sclerosis treatments, rheumatoid arthritis drugs, diabetes care, and other injectable medications increasingly delivered outside traditional clinical settings.

Demand is being shaped by the global shift toward home-based care, the expansion of injectable biologics, and the need to improve medication adherence while reducing avoidable clinic visits. For manufacturers, pharmaceutical sponsors, healthcare providers, and payers, the auto-injectors market is now a strategic intersection of device engineering, human factors validation, combination-product regulation, supply reliability, cold-chain readiness, and patient experience.

Transformative Shifts in the Auto-Injectors Landscape

The auto-injectors landscape is transforming as drug pipelines move toward larger molecules, more complex formulations, and patient-administered therapies. Pharmaceutical developers are prioritizing device-drug combinations that reduce injection anxiety, simplify dose delivery, and support differentiated lifecycle management for branded biologics, biosimilars, emergency medicines, and long-term specialty therapies.

Regulatory expectations are also reshaping development. Authorities such as the U.S. FDA and European regulators emphasize combination-product quality, usability engineering, risk management, labeling clarity, and post-market surveillance. At the same time, connected drug delivery, lower-waste device formats, recyclable materials, and resilient component sourcing are becoming competitive factors as healthcare systems demand better outcomes, lower waste, traceable quality, and more secure supply chains.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the auto-injectors value chain from concept development through post-market monitoring. AI-enabled simulation can help optimize ergonomics, injection force, needle safety, actuation reliability, and device robustness before physical prototyping, while machine vision supports automated inspection of molded parts, assemblies, labels, fill-finish integrity, and packaging quality in regulated manufacturing environments.

AI also improves demand planning, adverse-event signal detection, training personalization, and connected-device analytics when used with appropriate privacy, cybersecurity, validation, and human oversight controls. The cumulative impact is not a replacement for clinical evidence or regulatory compliance; it is a faster feedback loop that can reduce design iteration time, strengthen quality systems, improve complaint trending, and identify patient-use barriers earlier.

Key Regional Insights

North America remains a leading auto-injectors region due to advanced biologics adoption, established specialty pharmacy channels, strong reimbursement infrastructure, allergy awareness programs, and FDA oversight of combination products. Europe shows comparable maturity, supported by the European Medicines Agency framework, Medical Device Regulation requirements, pharmacovigilance systems, and strong adoption across Germany, France, Italy, Spain, and the United Kingdom.

Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia increase access to biologics, strengthen local pharmaceutical manufacturing, and expand chronic disease management programs. Latin America, led by Brazil and Mexico, is gradually improving access to self-injection therapies, although reimbursement variability, affordability, import dependence, and uneven specialty care access remain important constraints.

The Middle East is gaining relevance through investment in specialty care, diabetes management, allergy treatment, and hospital modernization, particularly in GCC markets. Africa remains an emerging opportunity where affordability, cold-chain reliability, trained healthcare workforces, procurement consistency, and access to emergency medicines will determine the pace of auto-injector uptake for anaphylaxis treatment and chronic disease therapies.

Key Group Insights

ASEAN markets are becoming more attractive as healthcare access expands, regulatory systems mature, and regional manufacturing ecosystems strengthen across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. The GCC is advancing through high healthcare investment, specialty treatment centers, diabetes and allergy care programs, and procurement systems that favor reliable, easy-to-use drug delivery systems.

The European Union represents one of the most structured environments for auto-injectors due to harmonized device regulation, pharmacovigilance requirements, quality system expectations, and established reimbursement pathways. BRICS countries provide scale through large patient populations, rising chronic disease prevalence, and growing biologics demand, but access varies significantly by public reimbursement, local manufacturing policy, pricing controls, and distribution capacity.

G7 markets continue to set standards in clinical adoption, regulatory science, device usability, patient training, and connected health integration. NATO countries, while not a healthcare market bloc, are relevant to emergency preparedness, resilient medical supply chains, and standardized procurement considerations for critical therapies such as epinephrine auto-injectors and other time-sensitive injectable medicines.

Key Country Insights

The United States leads in specialty drug commercialization, epinephrine auto-injector awareness, payer-driven access management, and FDA-regulated combination-product development, while Canada benefits from structured healthcare coverage, allergy guidance, and chronic disease management programs. Mexico and Brazil are the most important Latin American markets in scope, supported by expanding private healthcare access, biosimilar interest, and broader modernization of specialty treatment pathways.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong adoption potential due to developed healthcare systems, specialist prescribing, established reimbursement review processes, and mature regulatory oversight. Russia remains shaped by domestic manufacturing priorities, public procurement dynamics, and localization strategies, creating opportunities for compliant partnerships where supply continuity and regulatory alignment can be maintained.

China and India offer long-term demand potential driven by large patient populations, rising chronic disease prevalence, expanding pharmaceutical manufacturing, and improving access to advanced therapies. Japan, South Korea, and Australia provide advanced regulatory environments, high quality expectations, strong pharmacovigilance practices, and opportunities for premium auto-injector platforms linked to biologics, migraine therapies, emergency care, and autoimmune disease treatments.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize human factors engineering early in development, not as a late-stage validation exercise. Devices must be intuitive across age groups, dexterity levels, anxiety profiles, vision limitations, and emergency-use conditions, with clear labeling, audible or tactile feedback, low activation complexity, and robust needle-safety mechanisms.

Organizations should build resilient dual-source supply strategies for critical components, align device selection with formulation viscosity and dose volume, and prepare for regulatory scrutiny of combination-product risk files, usability evidence, cybersecurity documentation, and post-market monitoring. Partnerships with specialty pharmacies, payers, clinicians, patient advocacy groups, and digital health providers can improve training, persistence, and real-world evidence generation.

A practical growth strategy should also include sustainability assessments, connected-device governance, lifecycle management planning, and market-specific access strategies. Leaders that integrate device design, clinical value, reimbursement evidence, manufacturing quality, patient education, and supply-chain resilience will be best positioned to compete.

Research Methodology

The research methodology combines structured secondary research, regulatory review, product benchmarking, clinical guideline assessment, patent activity analysis, standards review, and expert-led validation. Sources include public regulatory databases, prescribing information, medical device and combination-product guidance, peer-reviewed literature, standards bodies, healthcare procurement references, public health resources, and verified industry disclosures.

Market interpretation is developed through triangulation across demand indicators, disease burden, biologics adoption, reimbursement conditions, device technology trends, patient-use requirements, manufacturing constraints, and regional access dynamics. Qualitative insights are assessed against verified public evidence to avoid unsupported claims and to provide decision-ready conclusions for executives, investors, product teams, regulatory teams, and market access leaders.

Conclusion

The auto-injectors market is evolving from a device category into a strategic platform for patient-centered pharmaceutical delivery. Momentum is supported by biologics expansion, self-care models, emergency medicine needs, chronic disease management, and rising expectations for safe, reliable, convenient, and lower-burden administration.

The next phase of competition will be defined by usability, regulatory readiness, manufacturing resilience, digital integration, sustainability, and regional access execution. Companies that combine proven device performance with patient training, strong evidence, scalable supply, and compliant lifecycle management will capture the most durable opportunities in the global auto-injectors ecosystem.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Auto-Injectors Market, by Product Type
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Auto-Injectors Market, by Dose Type
8.1. Introduction
8.2. Fixed Dose
8.3. Variable Dose
9. Auto-Injectors Market, by Route Of Administration
9.1. Introduction
9.2. Subcutaneous
9.3. Intramuscular
10. Auto-Injectors Market, by Container Format
10.1. Introduction
10.2. Prefilled Syringe
10.3. Cartridge Based
11. Auto-Injectors Market, by Injection Volume
11.1. Introduction
11.2. Up To 2 ML
11.3. 2 ML To 5 ML
11.4. Above 5 ML
12. Auto-Injectors Market, by Therapy Area
12.1. Introduction
12.2. Anaphylaxis
12.3. Rheumatoid Arthritis
12.4. Multiple Sclerosis
12.5. Migraine
12.6. Psoriasis
13. Auto-Injectors Market, by End User
13.1. Introduction
13.2. Home Care Settings
13.3. Hospitals & Clinics
13.4. Emergency Response Settings
14. Auto-Injectors Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacies
14.3. Retail Pharmacies
14.4. Online Pharmacies
15. Auto-Injectors Market, by Patient Type
15.1. Introduction
15.2. Adult
15.3. Pediatric
16. Auto-Injectors Market, by Region
16.1. Europe
16.2. North America
16.3. Asia-Pacific
16.4. Latin America
16.5. Middle East
16.6. Africa
17. Auto-Injectors Market, by Group
17.1. NATO
17.2. G7
17.3. European Union
17.4. BRICS
17.5. ASEAN
17.6. GCC
18. Auto-Injectors Market, by Country
18.1. United States
18.2. China
18.3. Germany
18.4. United Kingdom
18.5. France
18.6. Canada
18.7. Japan
18.8. India
18.9. Brazil
18.10. Mexico
18.11. Italy
18.12. South Korea
18.13. Australia
18.14. Russia
18.15. Spain
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. FPNV Positioning Matrix, 2025
19.3. Market Concentration Analysis, 2025
19.3.1. Concentration Ratio (CR)
19.3.2. Herfindahl Hirschman Index (HHI)
19.4. Recent Developments & Impact Analysis, 2025
19.5. Product Portfolio Analysis, 2025
19.6. Benchmarking Analysis, 2025
20. Company Profiles
20.1. Becton, Dickinson and Company
20.2. SHL Medical
20.3. Biogen Inc.
20.4. Ypsomed AG
20.5. Sanofi SA
20.6. Pfizer Inc.
20.7. AbbVie Inc.
20.8. Amgen Inc.
20.9. Eli Lilly and Company
20.10. Teva Pharmaceutical Industries Ltd.
20.11. Novartis AG
20.12. Johnson & Johnson Services Inc.
20.13. Viatris Inc.
20.14. Gerresheimer AG
20.15. Regeneron Pharmaceuticals, Inc.
20.16. Halozyme Therapeutics, Inc.
20.17. Merck KGaA
20.18. Kindeva Drug Delivery L.P.
20.19. ALK-Abelló A/S
20.20. Amneal Pharmaceuticals LLC
20.21. AptarGroup, Inc.
20.22. Ascendis Pharma A/S
20.23. Bayer Pharmaceuticals
20.24. Biocon Biologics Limited
20.25. Boehringer Ingelheim International GmbH
20.26. Bristol Myers Squibb Company
20.27. Celltrion, Inc.
20.28. CROSSJECT
20.29. Eisai Co., Ltd.
20.30. Fresenius Kabi AG
20.31. GlaxoSmithKline PLC
20.32. Injecto Group A/S
20.33. Jabil Inc.
20.34. Kaléo, Inc.
20.35. Owen Mumford Limited
20.36. SCHOTT Pharma AG & Co. KGaA
20.37. SMC Ltd.
List of Figures
FIGURE 1. GLOBAL AUTO-INJECTORS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL AUTO-INJECTORS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL AUTO-INJECTORS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL AUTO-INJECTORS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2025 VS 2032 (%)
FIGURE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2025 VS 2032 (%)
FIGURE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2025 VS 2032 (%)
FIGURE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
FIGURE 23. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL AUTO-INJECTORS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 27. GLOBAL AUTO-INJECTORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 29. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. GLOBAL AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 31. GLOBAL AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL AUTO-INJECTORS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DISPOSABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DISPOSABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DISPOSABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL REUSABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL REUSABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL REUSABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL FIXED DOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL FIXED DOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FIXED DOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL VARIABLE DOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL VARIABLE DOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL VARIABLE DOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PREFILLED SYRINGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PREFILLED SYRINGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PREFILLED SYRINGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CARTRIDGE BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CARTRIDGE BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CARTRIDGE BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL UP TO 2 ML MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL UP TO 2 ML MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL UP TO 2 ML MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL 2 ML TO 5 ML MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL 2 ML TO 5 ML MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL 2 ML TO 5 ML MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ABOVE 5 ML MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ABOVE 5 ML MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ABOVE 5 ML MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ANAPHYLAXIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ANAPHYLAXIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ANAPHYLAXIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL RHEUMATOID ARTHRITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL RHEUMATOID ARTHRITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL RHEUMATOID ARTHRITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MIGRAINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MIGRAINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MIGRAINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PSORIASIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL PSORIASIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PSORIASIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL EMERGENCY RESPONSE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL EMERGENCY RESPONSE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL EMERGENCY RESPONSE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. EUROPE AUTO-INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. EUROPE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 87. EUROPE AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 88. EUROPE AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 89. EUROPE AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 90. EUROPE AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 91. EUROPE AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 92. EUROPE AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 93. EUROPE AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 94. EUROPE AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 135. AFRICA AUTO-INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 137. AFRICA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 138. AFRICA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 139. AFRICA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 140. AFRICA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 141. AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 142. AFRICA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. AFRICA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 144. AFRICA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL AUTO-INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. NATO AUTO-INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. NATO AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 148. NATO AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 149. NATO AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 150. NATO AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 151. NATO AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 152. NATO AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 153. NATO AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. NATO AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. NATO AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 156. G7 AUTO-INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. G7 AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. G7 AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 159. G7 AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 160. G7 AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 161. G7 AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 162. G7 AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 163. G7 AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. G7 AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. G7 AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 176. BRICS AUTO-INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. BRICS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 178. BRICS AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 179. BRICS AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 180. BRICS AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 181. BRICS AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 182. BRICS AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 183. BRICS AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. BRICS AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 185. BRICS AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 186. ASEAN AUTO-INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. ASEAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 188. ASEAN AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 189. ASEAN AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 190. ASEAN AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 191. ASEAN AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 192. ASEAN AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 193. ASEAN AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 194. ASEAN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 195. ASEAN AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 196. GCC AUTO-INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 197. GCC AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 198. GCC AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 199. GCC AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 200. GCC AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 201. GCC AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 202. GCC AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 203. GCC AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. GCC AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. GCC AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 216. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 217. CHINA AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 218. CHINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. CHINA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 220. CHINA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 221. CHINA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 222. CHINA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 223. CHINA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 224. CHINA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. CHINA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. CHINA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 227. GERMANY AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. GERMANY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. GERMANY AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 230. GERMANY AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 231. GERMANY AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 232. GERMANY AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 233. GERMANY AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 234. GERMANY AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. GERMANY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 236. GERMANY AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 247. FRANCE AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. FRANCE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. FRANCE AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 250. FRANCE AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 251. FRANCE AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 252. FRANCE AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 253. FRANCE AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 254. FRANCE AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. FRANCE AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 256. FRANCE AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 257. CANADA AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. CANADA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 259. CANADA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 260. CANADA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 261. CANADA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 262. CANADA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 263. CANADA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 264. CANADA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. CANADA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 266. CANADA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 267. JAPAN AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 268. JAPAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 269. JAPAN AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 270. JAPAN AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 271. JAPAN AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 272. JAPAN AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 273. JAPAN AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 274. JAPAN AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. JAPAN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 276. JAPAN AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 277. INDIA AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 278. INDIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 279. INDIA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 280. INDIA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 281. INDIA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 282. INDIA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 283. INDIA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 284. INDIA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. INDIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. INDIA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 287. BRAZIL AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. BRAZIL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 289. BRAZIL AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 290. BRAZIL AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 291. BRAZIL AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 292. BRAZIL AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 293. BRAZIL AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 294. BRAZIL AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. BRAZIL AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 297. MEXICO AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. MEXICO AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. MEXICO AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 300. MEXICO AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 301. MEXICO AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 302. MEXICO AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 303. MEXICO AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 304. MEXICO AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. MEXICO AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. MEXICO AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 307. ITALY AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. ITALY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 309. ITALY AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 310. ITALY AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 311. ITALY AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 312. ITALY AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 313. ITALY AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 314. ITALY AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. ITALY AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 316. ITALY AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 317. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 322. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 323. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 324. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 326. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 327. AUSTRALIA AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 328. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 329. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 330. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 331. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 332. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 333. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 334. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 337. RUSSIA AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. RUSSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 339. RUSSIA AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 340. RUSSIA AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 341. RUSSIA AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 342. RUSSIA AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 343. RUSSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 344. RUSSIA AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. RUSSIA AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 346. RUSSIA AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 347. SPAIN AUTO-INJECTORS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. SPAIN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 349. SPAIN AUTO-INJECTORS MARKET SIZE, BY DOSE TYPE, 2017-2032 (USD MILLION)
TABLE 350. SPAIN AUTO-INJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 351. SPAIN AUTO-INJECTORS MARKET SIZE, BY CONTAINER FORMAT, 2017-2032 (USD MILLION)
TABLE 352. SPAIN AUTO-INJECTORS MARKET SIZE, BY INJECTION VOLUME, 2017-2032 (USD MILLION)
TABLE 353. SPAIN AUTO-INJECTORS MARKET SIZE, BY THERAPY AREA, 2017-2032 (USD MILLION)
TABLE 354. SPAIN AUTO-INJECTORS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 355. SPAIN AUTO-INJECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 356. SPAIN AUTO-INJECTORS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 357. GLOBAL AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 358. GLOBAL AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Becton, Dickinson and Company
  • SHL Medical
  • Biogen Inc.
  • Ypsomed AG
  • Sanofi SA
  • Pfizer Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Johnson & Johnson Services Inc.
  • Viatris Inc.
  • Gerresheimer AG
  • Regeneron Pharmaceuticals, Inc.
  • Halozyme Therapeutics, Inc.
  • Merck KGaA
  • Kindeva Drug Delivery L.P.
  • ALK-Abelló A/S
  • Amneal Pharmaceuticals LLC
  • AptarGroup, Inc.
  • Ascendis Pharma A/S
  • Bayer Pharmaceuticals
  • Biocon Biologics Limited
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Company
  • Celltrion, Inc.
  • CROSSJECT
  • Eisai Co., Ltd.
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Injecto Group A/S
  • Jabil Inc.
  • Kaléo, Inc.
  • Owen Mumford Limited
  • SCHOTT Pharma AG & Co. KGaA
  • SMC Ltd.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.22 Billion
Forecasted Market Value ( USD ) by 2032 $ 22.63 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned37

Related Topics

Related Reports

Epinephrine Auto-Injector Market - Global Forecast 2026-2032 - Product Image

Epinephrine Auto-Injector Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Autoinjectors Market Size, Share, & Trends Analysis by Product, Indication, End-use, Region, and Segment Forecasts, 2026-2033 - Product Image

Autoinjectors Market Size, Share, & Trends Analysis by Product, Indication, End-use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 160 Pages
  • Global
From
Prefilled Auto Injector Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Prefilled Auto Injector Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Insulin Injection Aids - Global Strategic Business Report - Product Image

Insulin Injection Aids - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Wearable Injector Market - Global Forecast 2026-2032 - Product Image

Wearable Injector Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.